Vitreomacular Adhesion (VMA) Global Clinical Trials Review, H2, 2018

GlobalData's clinical trial report, “Vitreomacular Adhesion (VMA) Global Clinical Trials Review, H2, 2018" provides an overview of Vitreomacular Adhesion (VMA) clinical trials scenario. This report provides top line data relating to the clinical trials on Vitreomacular Adhesion (VMA). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Oxurion NV

Novartis AG

Allegro Ophthalmics LLC

Lee's Pharmaceutical Holdings Ltd

Kato Pharmaceuticals Inc

Oxurion NV

Novartis AG

Allegro Ophthalmics LLC

Lee's Pharmaceutical Holdings Ltd

Kato Pharmaceuticals Inc

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Vitreomacular Adhesion (VMA) to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 17

Clinical Trials by E7 Countries: Proportion of Vitreomacular Adhesion (VMA) to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 20

Clinical Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Subjects Recruited Over a Period of Time 24

Clinical Trials by Sponsor Type 25

Prominent Sponsors 26

Top Companies Participating in Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials 27

Prominent Drugs 28

Clinical Trial Profile Snapshots 29

Appendix 42

Abbreviations 42

Definitions 42

Research Methodology 43

Secondary Research 43

About GlobalData 44

Contact Us 44

Source 45

List of Tables

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Region, 2018* 7

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* ...

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Region, 2018* 7

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14

Proportion of Vitreomacular Adhesion (VMA) to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 15

Vitreomacular Adhesion (VMA) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Proportion of Vitreomacular Adhesion (VMA) to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 18

Vitreomacular Adhesion (VMA) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Phase, 2018* 21

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24

Vitreomacular Adhesion (VMA) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 25

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28

List of Figures

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, ...

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14

Proportion of Vitreomacular Adhesion (VMA) to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 15

Vitreomacular Adhesion (VMA) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Proportion of Vitreomacular Adhesion (VMA) to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 18

Vitreomacular Adhesion (VMA) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24

Vitreomacular Adhesion (VMA) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 25

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27

Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28

GlobalData Methodology 43

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports